🔧На сайте запланированы технические работы
25.12.2025 в промежутке с 18:00 до 21:00 по Московскому времени (GMT+3) на сайте будут проводиться плановые технические работы. Возможны перебои с доступом к сайту. Приносим извинения за временные неудобства. Благодарим за понимание!
🔧Site maintenance is scheduled.
Scheduled maintenance will be performed on the site from 6:00 PM to 9:00 PM Moscow time (GMT+3) on December 25, 2025. Site access may be interrupted. We apologize for the inconvenience. Thank you for your understanding!

 

Formulation of perspective hepatoprotector polymeric forms based on silybin and ursodeoxycholic acid


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Silybin (Slb) and ursodeoxycholic acid (UDCA) are hepatoprotectors used in the pathogenetic therapy of liver and biliary tract. However, low bioavailability of these drugs restricts their application. In order to solve this problem, Slb and UDCA were incorporated into polymer carriers based on polylactic acid and poly(lactic-co-glycolic acid) by nanoprecipitation. The polymeric forms obtained according to the developed and optimized method are nanoparticles with a size from 100 to 200 μm. In vitro experiments showed a 1.5–2-fold higher hepatoprotective activity of Slb- and UDCA-containing polymeric nanoparticles compared to free substances.

About the authors

O. G. Tereshchenko

Russian Research Center for Molecular Diagnostics and Therapy

Email: e.severin@mail.ru
Russian Federation, 8 Simferopol´skii b-r, Moscow, 117638

E. D. Nikolskaya

Russian Research Center for Molecular Diagnostics and Therapy

Email: e.severin@mail.ru
Russian Federation, 8 Simferopol´skii b-r, Moscow, 117638

O. A. Zhunina

Russian Research Center for Molecular Diagnostics and Therapy

Author for correspondence.
Email: e.severin@mail.ru
Russian Federation, 8 Simferopol´skii b-r, Moscow, 117638

V. V. Zavarzina

National Research Center “Kurchatov Institute”

Email: e.severin@mail.ru
Russian Federation, 1 pl. Akad. Kurchatova, Moscow, 123098

N. G. Yabbarov

Russian Research Center for Molecular Diagnostics and Therapy

Email: e.severin@mail.ru
Russian Federation, 8 Simferopol´skii b-r, Moscow, 117638

M. V. Fomicheva

Russian Research Center for Molecular Diagnostics and Therapy

Email: e.severin@mail.ru
Russian Federation, 8 Simferopol´skii b-r, Moscow, 117638

E. V. Zubkov

Russian Research Center for Molecular Diagnostics and Therapy; Sechenov University, Ministry of Health of the Russian Federation

Email: e.severin@mail.ru
Russian Federation, 8 Simferopol´skii b-r, Moscow, 117638; 2 Build., 8 ul. Trubetskaya, Moscow, 119991

M. B. Sokol

Russian Research Center for Molecular Diagnostics and Therapy

Email: e.severin@mail.ru
Russian Federation, 8 Simferopol´skii b-r, Moscow, 117638

N. V. Gukasova

National Research Center “Kurchatov Institute”

Email: e.severin@mail.ru
Russian Federation, 1 pl. Akad. Kurchatova, Moscow, 123098

E. S. Severin

Russian Research Center for Molecular Diagnostics and Therapy

Email: e.severin@mail.ru
Russian Federation, 8 Simferopol´skii b-r, Moscow, 117638

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature